Dominant negative ER induces apoptosis in GH4 pituitary lactotrope cells and inhibits tumor growth in nude mice

Endocrinology

Volumn 142, Issue 9, 2001, Pages 3756-3763

  Lee, Eun Jig ^a   Duan, W Rachel ^a   Jakacka, Monika ^a   Gehm, Barry D ^a   Jameson, J Larry ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROLACTINOMA; REPORTER GENE;

EID: 0034875303     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.9.8372     Document Type: Article

References (50)

1. Estrogen control of prolactin synthesis in vitro
2. Estradiol regulates the transcription of the prolactin gene
3. Pituitary tumor registry: A novel clinical resource
4. Estradiol-induced prolactinomas: Differential effects on dopamine in posterior pituitary and median eminence
5. Pituitary tumors in mice exposed prenatally to diethylstilbestrol
6. Cellular receptors for sex steroids in human pituitary adenomas
7. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors
8. Differential expression of estrogen receptor-β (ERβ) in human pituitary tumors: Functional interactions with ER alpha and a tumor-specific splice variant
9. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors
10. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells
11. Estrogen receptor blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumour cells
12. Powerful dominant negative mutants of the human estrogen receptor
13. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors
14. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells
15. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation
16. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype
17. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone
18. Tissue-specific regulation of rat estrogen receptor mRNAs
19. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary
20. Differential regulation and action of estrogen receptors α and β in GH3 cells
21. Clonal strains of hormone-producing pituitary cells
22. Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells
23. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription
24. Targeted expression of toxic genes directed by pituitary hormone promoters: A potential strategy for adenovirus-mediated gene therapy of pituitary tumors
25. EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway
26. Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene
27. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins
28. Cross-inhibition of both estrogen receptor α and β pathways by each dominant negative mutant
29. Social controls on cell survival and cell death
30. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
31. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
32. Expression of bcl-2 oncoprotein in pituitary tumours: Comparison with c-myc
33. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: Relationship to tumour behaviour
34. Bromocriptine-induced apoptosis in pituitary adenoma cells: Relationship to p53 and bcl-2 expression
35. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
36. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
37. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
38. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
39. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens
40. Stable expression of the human estrogen receptor in HeLa cells by infection: Effect of estrogen on cell proliferation and c-myc expression
41. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor
42. Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis
43. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors, dissociation from transcriptional activity
44. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375
45. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389
46. 3 cells
47. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis
48. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents
49. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein
50. Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplastic anterior pituitaries